Lista de obras - Mats Brune - Dominio Público Uruguay

A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2008

Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

artículo científico publicado en 2000

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

artículo científico publicado en 2009

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

scientific article published on 28 April 2006

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

artículo científico publicado en 2019

Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes.

artículo científico publicado en 2012

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia

artículo científico publicado en 2019

Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia

artículo científico publicado en 2018

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens

scientific article published on 14 September 2006

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia

artículo científico publicado en 2016

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome.

artículo científico publicado en 2010

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

artículo científico publicado en 2011

High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

artículo científico publicado en 2019

Histamine and cytokine therapy

scientific article published on 01 January 1998

Histamine and interleukin-2 in acute myelogenous leukemia

scientific article published on 01 November 1997

Histamine and the Response to IFN-α in Chronic Hepatitis C ⬇️

artículo científico publicado el 1 de enero de 1998

Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.

artículo científico publicado en 2009

Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.

artículo científico publicado en 2009

Histamine in cancer immunotherapy

artículo científico publicado en 1997

Histamine protects T cells and natural killer cells against oxidative stress

scientific article published on 01 October 1999

Histamine, cimetidine and colorectal cancer

artículo científico publicado en 1996

Histamine: a novel approach to cancer immunotherapy.

artículo científico publicado en 2000

Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2013

Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.

artículo científico publicado en 2015

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype

scientific article published on 24 July 2019

Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia

artículo científico publicado en 2014

Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia

artículo científico publicado en 2010

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia

artículo científico publicado en 2017

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

artículo científico publicado en 2006

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

artículo científico publicado en 2019

Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study ⬇️

artículo científico publicado en 2016

Incidence and outcome of acquired aplastic anemia-real-world data from patients diagnosed in Sweden from 2000-2011.

artículo científico publicado en 2017

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

scientific article published on 29 August 2002

Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study.

artículo científico publicado en 2018

Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report

scientific article published on 01 July 1996

Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation

artículo científico publicado en 2011

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

artículo científico publicado en 2018

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

artículo científico publicado en 2001

Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis

artículo científico publicado en 2012

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.

artículo científico publicado en 2015

NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites

scientific article published on 01 October 1996

NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species

artículo científico publicado en 2006

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

artículo científico publicado en 2017

Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine

scientific article published on 01 September 2000

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

artículo científico publicado en 2005

Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML.

artículo científico publicado en 2009

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease

artículo científico publicado en 2012

Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.

artículo científico publicado en 2012

Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukaemia

scientific article published on 01 March 1996

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2001

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

artículo científico publicado en 2009

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia

artículo científico publicado en 2015

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy

artículo científico publicado en 2017

Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting

artículo científico publicado en 2019

The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia

artículo científico publicado en 2019

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries

artículo científico publicado en 2011

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

scientific article published on 10 July 2013

[Stem cell transplantation in metastasized renal cancer]

artículo científico publicado en 2001

Lista de obras de Mats Brune

A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation

Alleviating oxidative stress in cancer immunotherapy: a role for histamine?

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry

Chronic myeloid leukemic cells trigger poly(ADP-ribose) polymerase-dependent inactivation and cell death in lymphocytes.

Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia

Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens

Dynamics of cytotoxic T cell subsets during immunotherapy predicts outcome in acute myeloid leukemia

Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome.

Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study

Histamine and cytokine therapy

Histamine and interleukin-2 in acute myelogenous leukemia

Histamine and the Response to IFN-α in Chronic Hepatitis C ⬇️

Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.

Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.

Histamine in cancer immunotherapy

Histamine protects T cells and natural killer cells against oxidative stress

Histamine, cimetidine and colorectal cancer

Histamine: a novel approach to cancer immunotherapy.

Human parvovirus B19 in pediatric and adult recipients of allogeneic hematopoietic stem cell transplantation

Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype

Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia

Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study ⬇️

Incidence and outcome of acquired aplastic anemia-real-world data from patients diagnosed in Sweden from 2000-2011.

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study.

Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report

Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance.

NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites

NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML.

Rapid salvage treatment with virus-specific T cells for therapy-resistant disease

Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells.

Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukaemia

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

Role of natural killer cell subsets and natural cytotoxicity receptors for the outcome of immunotherapy in acute myeloid leukemia

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy

Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting

The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia

The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

[Stem cell transplantation in metastasized renal cancer]